Living EuroGuiDerm Guideline for the systemic treatment of psoriasis vulgaris
 

The general recommendations developed in this guideline are based on the Living Cochrane review published in January 2020. With new evidence and new results becoming available, the guideline development group will consider these and decide if and when an update is necessary. This will also be the case for the recommendations for specific clinical and comorbid situations. 

Download entire guideline in the most up-to-date version:

Last updated

Changes since last version

 

Download

 

Introduction, scoping, population and targeted users

07/2020

Original version

Disease severity and treatment goals

07/2020

Original version

Methods and evidence
section 

07/2020

Original version

Main Recommendations and Decision Grid

09/2020

Original version

Strength and limitations

07/2020

Original version

References

07/2020

Original version

Abbreviations

07/2020

Original version

Contains intructions for use, recommendations for lab controls, adverse drug reactions, special consideration during treatment, important contraindications and drug interactions                                            

Last updated

Changes since last version

 

Download

 

Acitretin

07/2020

Original version

Ciclosporin

07/2020

Original version

Fumarates

07/2020

Original version

Methotrexate

07/2020

Original version

Adalimumab

07/2020

Original version

Apremilast

07/2020

Original version

Brodalumab

07/2020

Original version

Certolizumab – Pegol

07/2020

Original version

Etanercept

07/2020

Original version

Guselkumab

07/2020

Original version

Infliximab

07/2020

Original version

Ixekizumab

07/2020

Original version

Risankizumab

07/2020

Original version

Secukinumab

07/2020

Original version

Tildrakizumab

07/2020

Original version

Ustekinumab

07/2020

Original version

Biosimilars

07/2020

Original version

Newly approved medications
and treatments in the pipeline

07/2020

Original version

Last updated

Changes since last version

 

Download

 

Psoriatic arthritis

07/2020

Original version

Inflammatory bowel disease

07/2020

Original version

Cancer

07/2020

Original version

Depression

07/2020

Original version

Diabetes

07/2020

Original version

Heart disease

07/2020

Original version

Kidney disease

07/2020

Original version

Neurological diseases

07/2020

Original version

Viral Hepatitis

07/2020

Original version

Tuberculosis: Screening

07/2020

Original version

Tuberculosis: Management

07/2020

Original version

Wish for child / Pregnancy

07/2020

Original version

Vaccinations

07/2020

Original version

Covid-19

07/2020

Original version

Inmunogenicity

07/2020

Original version

Last updated

Changes since last version

 

Download

 

Methods Report

09/2020

Original version

IFPA Guideline

09/2020

Original version

Implementation slides

07/2020

Original version